Answers are grounded in this paper and cite their sources.
In 2000, Breast Cancer Research published a series of articles describing the state-of-the-art of breast cancer imaging, edited by James Basilion This series reviewed developments in magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), radionuclide imaging with single-photon emission computed tomography (SPECT) and positron emission tomogrophy (PET), and optical imaging, including optical computed tomography and near infra-red imaging fluorescence. The series had an emphasis on technical development, pre-clinical research, and early clinical studies. Five years later, we revisit the same areas of breast cancer imaging with an eye towards ongoing translational research and new opportunities to detect breast cancer early and to direct effective, individualized therapy.
No takes yet. Share an insight, caveat, or question.
David A. Mankoff (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: